BioVenture VoiCes with Chris Garabedian cover image

Episode 34: General Atlantic's Brett Zbar

BioVenture VoiCes with Chris Garabedian

00:00

Oncology and INI risk preferences

Brett says GA prefers de-risked biology or strong teams, often seeking clinical data before investing in oncology.

Play episode from 51:57
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app